Buprenorphine

CAS 52485-79-7 14 current records 1 historicalSmall Molecule

Who holds supplier records for Buprenorphine? 14 organisations hold a current record for Buprenorphine: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 11 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: Germany (2), United States (2), India (2), Netherlands (1) and 3 other countries (3); not recorded for 4.

Most records are filed under another form of this substance: Buprenorphine Hydrochloride (18 current sources). A DMF or CEP is listed under the form it names.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Buprenorphine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/buprenorphine

Reading the evidence

  • 14 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 5 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Buprenorphine expires 22 Jun 2038. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (14)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Buprenorphine. Country is the organisation's recorded country, not necessarily the manufacturing site.

Germany2United States2India2Netherlands1Czech Republic1Switzerland1Denmark1Country not recorded for 4
  • Arevipharma GmbH
    Active DMF 27547 · latest filing Sept 2013
    GermanyCEP Company GMP cert on record
  • NORAMCO INC
    Active DMF 30762 · latest filing Aug 2016
    United StatesCEP
  • SIEGFRIED LTD
    Active DMF 26052 · latest filing May 2012
    CEP
  • SPECGX LLC
    Active DMF 24927 · latest filing May 2012
    United StatesCEP
  • MACFARLAN SMITH LTD A JOHNSON MATTHEY CO
    Active DMF 26448 · latest filing Sept 2012
  • SIEGFRIED USA LLC
    Active DMF 29091 · latest filing Mar 2015
    Germany
  • TAPI NL BV
    Active DMF 28075 · latest filing Mar 2014
    Netherlands
  • MACFARLAN SMITH LTD
    CEP Company GMP cert on record
  • IndiaCEP Company GMP cert on record
  • SIEGFRIED AG
    CEP Company GMP cert on record
  • TAPI Czech Industries s.r.o
    Czech RepublicCEP Company GMP cert on record
  • AZAD PHARMA AG
    Valid CEP holder (EDQM); not necessarily the manufacturer
    SwitzerlandCEP
  • PIONEER AGRO INDUSTRIES SANVIN LABORATORIES PRIVATE LIMITED
    Valid CEP holder (EDQM); not necessarily the manufacturer
    IndiaCEP
  • CHR. OLESEN SYNTHESIS A/S Hvidovre
    Valid CEP holder (EDQM); not necessarily the manufacturer
    DenmarkCEP
Need Buprenorphine sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (11)

Certificates of Suitability on the EDQM register for Buprenorphine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 18 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
AZAD PHARMA AG SchaffhausenCH
CEP 2023-254 - Rev 01
Buprenorphine
Sept 2026—
TAPI CZECH INDUSTRIES S.R.O. OpavaCZ
CEP 2008-041 - Rev 06
Buprenorphine
Jun 2026Inspected Oct 2024
Czechia
SIEGFRIED AG ZofingenCH
CEP 2024-312 - Rev 01
Buprenorphine, Process II
Jun 2026Inspected Feb 2025
Switzerland
NORAMCO, LLC. WilmingtonUS
CEP 2007-190 - Rev 06
Buprenorphine
Mar 2026—
SPECGX LLC Webster GrovesUS
CEP 2025-111 - Rev 00
Buprenorphine, Process II
Nov 2025—
AREVIPHARMA GMBH RadebeulDE
CEP 2021-298 - Rev 01
Buprenorphine, Process N
Feb 2024Inspected Jun 2025
Germany
PIONEER AGRO INDUSTRIES SANVIN LABORATORIES PRIVATE LIMITED MumbaiIN
CEP 2005-096 - Rev 01
Buprenorphine
Oct 2023—
RUSAN PHARMA LTD MumbaiIN
R1-CEP 2015-387 - Rev 00
Buprenorphine
Nov 2022—
CHR. OLESEN SYNTHESIS A/S HvidovreDK
R0-CEP 2021-098 - Rev 00
Buprenorphine
Nov 2022—
SIEGFRIED LTD. ZofingenCH
R1-CEP 2007-324 - Rev 01
Buprenorphine
May 2022—
MACFARLAN SMITH LIMITED EdinburghGB
R1-CEP 2006-009 - Rev 04
Buprenorphine
Dec 2019—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (1)

Organisations whose Type II DMFs for Buprenorphine are no longer active. These show a past filing, not current supply.

Show all 1 historical record
  • DIOSYNTH BV
    Inactive DMF 8542 · filed Apr 1990

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (63 listed products contain Buprenorphine). The latest listed patent expires 22 Jun 2038. The latest listed exclusivity runs to 21 Feb 2028. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Buprenorphine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL511142).

Chemical identity

IUPAC name
(1S,2S,6R,14R,15S,16R)-5-(cyclopropylmethyl)-16-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol
Canonical SMILES
C[C@]([C@H]1C[C@@]23CC[C@]1([C@H]4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)(C(C)(C)C)O
InChIKey
RMRJXGBAOAMLHD-CTAPUXPBSA-N
Synonyms
Brixadi, Bupeaze, Buplast, Buprenorfina, Buprenorphin, Buprenorphine, BUPRENORPHINE COMPONENT OF ALKS-5461, Butec, Butrans, Buvidal, Hapoctasin, Panitaz

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Partial Opioid Agonist
Mechanism of action
Partial Opioid Agonists

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Buprenorphine?

14 organisations hold an active US FDA Type II Drug Master File or a CEP for Buprenorphine: Arevipharma GmbH (Germany), NORAMCO INC (United States), SIEGFRIED LTD, SPECGX LLC (United States), MACFARLAN SMITH LTD A JOHNSON MATTHEY CO, SIEGFRIED USA LLC (Germany), TAPI NL BV (Netherlands) and MACFARLAN SMITH LTD, and 6 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Buprenorphine Drug Master Files are active?

Arevipharma GmbH (DMF 27547), NORAMCO INC (DMF 30762), SIEGFRIED LTD (DMF 26052), SPECGX LLC (DMF 24927), MACFARLAN SMITH LTD A JOHNSON MATTHEY CO (DMF 26448), SIEGFRIED USA LLC (DMF 29091) and TAPI NL BV (DMF 28075). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Buprenorphine records mean?

1 organisation has only inactive Type II DMFs for Buprenorphine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Buprenorphine have a European Certificate of Suitability?

Yes. 11 organisations hold a valid CEP for Buprenorphine on the EDQM register, including AZAD PHARMA AG Schaffhausen (CH), TAPI CZECH INDUSTRIES S.R.O. Opava (CZ), SIEGFRIED AG Zofingen (CH), NORAMCO, LLC. Wilmington (US), SPECGX LLC Webster Groves (US) and AREVIPHARMA GMBH Radebeul (DE) and 5 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Buprenorphine?

Yes. The latest patent listed for an approved US product containing Buprenorphine expires 22 Jun 2038, across 63 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Buprenorphine supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Buprenorphine?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.